Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium-Reference-Cited by-同舟云学术

Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium

Published:2022-05-20 Issue:8 Volume:27 Page:1348-1355
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Tohi Yoichiro^ORCID,Kato Takuma,Fukuhara Hideo,Kobayashi Keita,Ohira Shin,Ikeda Kenichiro,Daizumoto Kei,Katayama Satoshi,Shimizu Ryutaro,Nishimura Kenichi,Nagami Taichi,Hayashida Yushi,Hirama Hiromi,Takamoto Atsushi,Dainichi Teruki,Sugimoto Mikio,Inoue Keiji,Yamamoto Shinkuro,Matsuyama Hideyasu,Nagai Atsushi,Hinata Nobuyuki,Kanayama Hiroomi,Nasu Yasutomo,Takenaka Atsushi,Saika Takashi,Wada Koichiro,Tohi Yoichiro^ORCID,Kato Takuma,Fukuhara Hideo,Kobayashi Keita,Ohira Shin,Ikeda Kenichiro,Daizumoto Kei,Katayama Satoshi,Shimizu Ryutaro,Nishimura Kenichi,Nagami Taichi,Takamoto Atsushi,Sugimoto Mikio,

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10147-022-02183-z.pdf

Reference17 articles.

1. Smith MR, Saad F, Chowdhury S et al (2021) Apalutamide and overall survival in prostate cancer. Eur Urol 79:150–158

2. Chi KN, Agarwal N, Bjartell A et al (2019) Apalutamide for metastatic, castration-sensitive prostate cancer. N Engl J Med 381:13–24

3. National Comprehensive Cancer Network Clinical practice guidelines in oncology prostate cancer version 3 (2022)

4. Cornford P, van den Bergh RCN, Briers E et al (2021) EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer. Eur Urol 79:263–282

5. Uemura H, Koroki Y, Iwaki Y et al (2020) Skin rash following administration of apalutamide in Japanese patients with advanced prostate cancer: an integrated analysis of the phase 3 Spartan and Titan studies and a phase 1 open-label study. BMC Urol 20:139

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous Adverse Reactions to Apalutamide: Case Series with Clinical and Pathological Correlations;Acta Dermato-Venereologica;2024-09-04

2. Real‐world study: Impact of multidisciplinary management of apalutamide‐associated adverse events in prostate cancer;The Prostate;2024-06-18

3. Real-world analysis of apalutamide-associated skin rash in Chinese patients with prostate cancer;World Journal of Urology;2024-03-20

4. Case report: Apalutamide-induced severe lethal cutaneous adverse effects in China;Frontiers in Immunology;2024-01-11

5. Real-world prostate-specific antigen reduction and survival outcomes of metastatic hormone-sensitive prostate cancer patients treated with apalutamide: An observational, retrospective, and multicentre study.;Prostate International;2023-11